Background
Method
Search strategy
Eligibility criteria
Data extraction
Methodology assessment
Statistical analysis
Results
Search results
Study characteristics
Author (year) | Country | Study design | Simultaneous bilateral THA | Staged bilateral THA | Mean follow-up (range) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Age (mean, year) | Gender (male/female) | BMI (mean. Kg/m2) | ASA (1/2/3/4) (percentage) | n | Age (mean, years) | Gender (male/female) | BMI (mean. Kg/m2) | ASA (1/2/3/4) (percentage) | Time interval between stages | ||||
Agarwal et al. (2016) | India | Retrospective cohort | 48 | 52 | 20:28 | – | – | 56 | 54 | 26:30 | – | – | 4.2 days | 70 (36–82 months) |
Aghayev et al. (2010) | Switzerland | Registry | 247 | 59 | 116:131 | – | – | 1572 | 62.5 | 786:786 | – | – | – | 60 months |
Alfaro-Adrián et al. (1999) | Brazil | Retrospective cohort | 95 | 65 | 40:55 | – | 43/37/19/1 | 107 | 63.9 | 42:65 | – | 60/29/8/3 | 10.1 months | – |
Berend et al. (2007) | USA | Retrospective cohort | 167 | 52.7 | 100:67 | 29.7 | – | 110 | 57.3 | 47:63 | 30.8 | – | 8.1 months | 28.5 months |
Bhan et al. (2006) | India | Randomized clinical trial | 83 | 46.6 | 54:29 | – | 59/31/10/0 | 85 | 43.4 | 51:34 | – | 64/29/6/1 | 3–7 months | 60 months |
Brown et al. (2017) | USA | Retrospective cohort | 15 | 56.9 | 8:7 | 26.4 | Mean = 1.8 ± 0.6 | 44 | 60.2 | 24:20 | 27.8 | Mean = 2.2 ± 0.6 | 0.90 ± 0.89 years | 3 months |
Calabro et al. (2020) | Australia | Registry | 2779 | – | 6214:6145** | – | 19/60/20/1 | 9580 | – | 6214:6145** | – | 10/58/30/2 | – | Minimum = 1.5 years |
Eggli et al. (1995) | Switzerland | Prospective cohort | 64 | 54 | 133:122** | – | – | 191 | 61 | 133:122** | – | – | 96 days | 1.5 years |
Garland et al. (2015) | Sweden | Registry | 1680 | – | 767:913 | 26.9 | 33/54/13/0 | 40,558 | – | 16,356:24,202 | 27.4 | 23/61/16/0 | – | to the day of death |
Goh et al. (2022) | USA | Retrospective cohort | 220 | 60.8 | 341:330Δ | 30 | – | 170 | 64 | 123:210Δ | 30.7 | – | – | 3 months |
Guo et al. (2020) | China | Retrospective cohort | 863 | 49 | 604:259 | 24.7 | 31/68/1/0 | 282 | 52.5 | 152:130 | 24.8 | 27/69/4/0 | – | Minimum = 3 months |
Hooper et al. (2009) | New Zealand | Registry | 303 | 61 | – | – | – | 743 | 61 | – | – | – | – | 6 months |
Hou et al. (2021) | China | Retrospective case control | 100 | 54 | 30:70 | 24.6 | – | 100 | 57 | 29:71 | 24.6 | – | – | – |
Houdek et al. (2017) | USA | Retrospective case control | 94 | 52.2 | 54:40 | 27.1 | 7/78/15/0 | 94 | 52.1 | 54:40 | 27.8 | 7/80/13/0 | 3 months | 48 months |
Inoue et al. (2021) | USA | Retrospective cohort | 256 | 58.2 | 155:101 | 27.8 | – | 387 | 62.5 | 176:211 | 28.4 | – | 31.5 months | 90 days |
Johnston et al. (2011) | Scotland | Retrospective cohort | 68 | 61.5 | 26:42 | 27.4 | – | 526 | 66.5 | 208:318 | 27.2 | – | – | 1.5 years (24–108 months) |
Kamath et al. (2016) | Switzerland | Retrospective cohort | 41 | 60.7 | 24:17 | – | 18/58/24/0 | 44 | 68.7 | 18:26 | – | 12/65/23/0 | – | Minimum = 24 months |
Kim et al. (2017) | South Korea | Retrospective cohort | 63 | 43.1 | 39:24 | 22.9 | 30/60/10/0 | 60 | 43.5 | 32:28 | 23.3 | 30/66/4/0 | 4.8 months | 60.2 months |
Lindberg‑Larsen et al. (2013) | Denmark | Registry | 103 | 55.7 | 59:44 | – | – | 577 | 66.9 | 234:343 | – | – | – | Max = 415 days |
Lorenze et al. (1998) | USA | Retrospective case control | 40 | – | 20:20 | – | – | 40 | – | 20:20 | – | – | – | – |
Martin et al. (2016) | Canada | Retrospective case control | 12 | 58.9 | – | 27.9 | Mean = 2.2 ± 0.4 | 12 | 63.9 | – | 26.3 | Mean = 2.2 ± 0.6 | – | – |
Mou et al. (2021) | China | Retrospective cohort | 11 | – | 10:1 | 22.7 | – | 12 | – | 10:2 | 22.7 | – | 40.8 days | 80.9 months |
Panchal et al. (2021) | India | Retrospective case control | 54 | – | 27:27 | – | – | 54 | – | 27:27 | – | – | – | 62.4 months |
Partridge et al. (2019) | UK | Registry | 2507 | 60.6 | 1178:1329 | – | – | 9915 | 65.5 | 3966:5949 | – | – | – | 3 months |
Parvizi et al. (2006) | USA | Retrospective case control | 98 | 53 | 53:45 | 28.8 | 11/72/17/0 | 98 | 65 | 46:52 | 30.2 | 1/51/48/0 | 138 days | Minimum = 6 months |
Poultsides et al. (2017) | USA | Retrospective cohort | 1946 | 56.3 | 1000:946 | – | – | 1839 | 63.1 | 746:1093 | – | – | 5–365 days | – |
Quadri et al. (2015) | Pakistan | Retrospective cohort | 34 | 39 | 30:4 | 25 | 29/57/7/7 | 14 | 42 | 6:8 | 27 | 14/57/29/0 | – | – |
Rasouli et al. (2014) | USA | National database | 14,798 | 58.4 | – | – | – | 1532 | 60.3 | – | – | – | – | – |
Reuben et al. (1998) | USA | Retrospective case control | 7 | 49 | 4:3 | – | Mean = 2.5 ± 0.5 | 8 | 57 | 1:7 | – | Mean = 1.7 ± 0.7 | – | – |
Saito et al. (2010) | Japan | Retrospective case control | 49 | 59 | 6:43 | 23.5 | – | 40 | 61.9 | 4:36 | 23.8 | – | 30.7 days | 5.5 years (24–120 months) |
Salvati et al. (1978) | USA | Retrospective cohort | 122 | – | – | – | – | 339 | – | – | – | – | – | 36 months |
Schlegelmilch et al. (2017) | Canada | Retrospective case control | 26 | – | – | – | – | 6 | – | – | – | – | – | 12 months |
Seol et al. (2015) | Korea | Retrospective cohort | 147 | 41.9 | 112:35 | 23.7 | 54/41/5/0 | 59 | 46.3 | 45:14 | 23.8 | 46/46/8/0 | 18.7 months | 34.4 months |
Shih et al.
(1985) | China | Retrospective cohort | 20 | 40.7 | 17:3 | – | – | 15 | 46.6 | 13:2 | – | – | – | 365–530 days |
Taheriazam et al. (2019) | Iran | Randomized clinical trial | 90 | 59.3 | 59:31 | 28.4 | score 1 or 2 | 90 | 59.1 | 52:38 | 28.7 | score 1 or 2 | 6–12 months | 24 months |
Tan et al. (2019) | China | Retrospective cohort | 256 | 52 | 143:113 | 23.8 | 41/49/8/2 | 256 | 54.9 | 120:136 | 23.8 | 38/54/7/1 | – | 3 months |
Triantafyllopoulos et al. (2016) | USA | Retrospective cohort | 1808 | 56.3 | 930:878 | – | – | 4842 | 62.3 | 1995:2847 | – | – | 249–1710 days | 112.6 months |
Villa et al. (2019) | USA | Retrospective cohort | 61 | 55.4 | 40:21 | 27.5 | 15/69/16/0 | 143 | 63.1 | 63:80 | 27.7 | 7/69/24/0 | 461 | – |
Quality assessment
Author | Year | Study type | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias |
---|---|---|---|---|---|---|---|---|---|
Bhan et al. | 2006 | Randomized clinical trial | Yes | Unclear | Unclear | Yes | Yes | Yes | No bias |
Taheriazam et al. | 2019 | Randomized clinical trial | Yes | Yes | Unclear | Yes | Yes | Unclear | No bias |
Newcastle–Ottawa Scale (NOS) | ||||||
---|---|---|---|---|---|---|
Selection | Comparability | Exposure/Outcome | Total score | |||
Agarwal et al. | 2016 | Retrospective cohort | 3 | 1 | 2 | 6 |
Aghayev et al. | 2010 | Registry | 3 | 1 | 2 | 6 |
Alfaro-Adrián et al. | 1999 | Retrospective cohort | 3 | 1 | 2 | 6 |
Berend et al. | 2007 | Retrospective cohort | 3 | 1 | 2 | 6 |
Brown et al. | 2017 | Retrospective cohort | 3 | 2 | 1 | 6 |
Calabro et al. | 2020 | Registry | 3 | 2 | 2 | 7 |
Eggli et al. | 1995 | Prospective cohort | 3 | 2 | 2 | 7 |
Garland et al. | 2015 | Registry | 3 | 1 | 2 | 6 |
Goh et al. | 2022 | Retrospective cohort | 3 | 1 | 1 | 5 |
Guo et al. | 2020 | Retrospective cohort | 3 | 1 | 2 | 6 |
Hooper et al. | 2009 | Registry | 3 | 1 | 2 | 6 |
Hou et al. | 2021 | Retrospective case control | 3 | 1 | 2 | 6 |
Houdek et al. | 2017 | Retrospective case control | 3 | 1 | 2 | 6 |
Inoue et al. | 2021 | Retrospective cohort | 3 | 1 | 1 | 5 |
Johnston et al. | 2011 | Retrospective cohort | 4 | 1 | 2 | 7 |
Kamath et al. | 2016 | Retrospective cohort | 4 | 2 | 2 | 8 |
Kim et al. | 2017 | Retrospective cohort | 3 | 2 | 2 | 7 |
Lindberg‑Larsen et al. | 2013 | Registry | 4 | 1 | 2 | 7 |
Lorenze et al. | 1998 | Retrospective case control | 3 | 1 | 1 | 5 |
Martin et al. | 2016 | Retrospective case control | 4 | 1 | 0 | 5 |
Mou et al. | 2021 | Retrospective cohort | 4 | 1 | 2 | 7 |
Panchal et al. | 2021 | Retrospective case control | 3 | 2 | 2 | 7 |
Partridge et al. | 2019 | Registry | 3 | 2 | 2 | 7 |
Parvizi et al. | 2006 | Retrospective case control | 3 | 1 | 2 | 6 |
Poultsides et al. | 2017 | Retrospective cohort | 3 | 2 | 1 | 6 |
Quadri et al. | 2015 | Retrospective cohort | 3 | 2 | 2 | 7 |
Rasouli et al. | 2014 | National database | 3 | 1 | 2 | 6 |
Reuben et al. | 1998 | Retrospective case control | 3 | 1 | 1 | 5 |
Saito et al. | 2010 | Retrospective case control | 4 | 1 | 2 | 7 |
Salvati et al. | 1978 | Retrospective cohort | 3 | 1 | 1 | 5 |
Schlegelmilch et al. | 2017 | Retrospective case control | 3 | 1 | 1 | 5 |
Seol et al. | 2015 | Retrospective cohort | 3 | 1 | 1 | 5 |
Shih et al. | 1985 | Retrospective cohort | 2 | 1 | 2 | 5 |
Tan et al. | 2019 | Retrospective cohort | 3 | 2 | 1 | 6 |
Triantafyllopoulos et al. | 2016 | Retrospective cohort | 3 | 1 | 2 | 6 |
Villa et al. | 2019 | Retrospective cohort | 4 | 1 | 2 | 7 |
Mortality and complications
Author | Year | Simultaneous bilateral THA | Staged bilateral THA | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mortality (n) | Deep infection (n) | Fracture (n) | Dislocation (n) | DVT (n) | PE (n) | Pulmonary complication (n) | Local complications (n) | Systemic complications (n) | Mortality (n) | Deep infection (n) | Fracture (n) | Dislocation (n) | DVT (n) | PE (n) | Pulmonary complication (n) | Local complications (n) | Systemic complications (n) | ||
Agarwal et al. | 2016 | – | 1 | 1 | – | 0 | 0 | – | 3 | 0 | – | 1 | 1 | – | 0 | 0 | – | 2 | 0 |
Aghayev et al. | 2010 | – | – | 16 | 4 | 0 | 1 | 0 | 24 | 26 | – | – | 87 | 16 | 28 | 19 | 19 | 201 | 260 |
Alfaro-Adrián et al. | 1999 | 1 | – | 2 | 4 | 0 | 1 | – | 7 | 39 | 0 | – | 0 | 2 | 4 | 1 | – | 14 | 37 |
Berend et al. | 2007 | – | – | – | 4 | – | – | – | – | – | – | – | – | 0 | – | – | – | – | – |
Bhan et al. | 2006 | 0 | 2 | 1 | 0 | 3 | 1 | 0 | 4 | 11 | 0 | 1 | 1 | 1 | 2 | 0 | 1 | 3 | 6 |
Brown et al. | 2017 | – | – | – | – | 0 | 0 | – | – | – | – | – | – | – | 0 | 0 | – | – | – |
Calabro et al. | 2020 | 3 | 24 | 34 | 10 | – | – | – | – | – | 5 | 95 | 95 | 91 | – | – | – | – | – |
Eggli et al. | 1995 | – | – | 11 | 1 | 0 | 2 | 0 | 18 | 13 | – | – | 17 | 2 | 3 | 5 | 1 | 36 | 28 |
Garland et al. | 2015 | 26 | – | – | – | – | – | – | – | – | 1013 | – | – | – | – | – | – | – | – |
Goh et al. | 2022 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Guo et al. | 2020 | – | 3 | – | 1 | 42 | 2 | 17 | 12 | 118 | – | 1 | – | 3 | 15 | 2 | 8 | 10 | 51 |
Hooper et al. | 2009 | 0 | 16 | – | – | 1 | 1 | – | – | 2 | 1 | 15 | – | – | 4 | 1 | – | – | 5 |
Hou et al. | 2021 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Houdek et al. | 2017 | 0 | 3 | 6 | 5 | – | – | – | 10 | 2 | 0 | 3 | 7 | 4 | – | – | – | 18 | 2 |
Inoue et al. | 2021 | – | – | – | – | 0 | 0 | – | – | – | – | – | – | – | 0 | 0 | – | – | – |
Johnston et al. | 2011 | – | – | – | 4 | 0 | 0 | – | 4 | – | – | – | – | 17 | 0 | 8 | – | 8 | – |
Kamath et al. | 2016 | 0 | 0 | – | 0 | – | – | – | 3 | – | 0 | 0 | – | 0 | – | – | – | 2 | – |
Kim et al. | 2017 | 2 | 0 | 10 | 0 | – | – | – | – | – | 1 | 2 | 7 | 0 | – | – | – | – | – |
Lindberg‑Larsen et al. | 2013 | 0 | – | 1 | – | 0 | – | – | – | – | 2 | – | 5 | – | 16 | – | – | – | – |
Lorenze et al. | 1998 | – | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | – | 0 | 1 | 0 | 1 | 0 | 0 | 1 | 1 |
Martin et al. | 2016 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Mou et al. | 2021 | – | – | 1 | 1 | – | – | – | 3 | – | – | – | 0 | 0 | – | – | – | 3 | – |
Panchal et al. | 2021 | 0 | 0 | – | 0 | 0 | – | – | – | – | 1 | 0 | – | 0 | 0 | – | – | – | – |
Partridge et al. | 2019 | 10 | – | – | – | – | 35 | – | – | – | 10 | – | – | – | – | 40 | – | – | – |
Parvizi et al. | 2006 | 0 | – | – | – | – | 1 | 1 | – | 12 | 0 | – | – | – | – | 0 | 4 | – | 30 |
Poultsides et al. | 2017 | 1 | – | – | – | – | 16 | 38 | 6 | 279 | 0 | – | – | – | – | 11 | 64 | 7 | 374 |
Quadri et al. | 2015 | – | – | – | 1 | – | – | – | – | – | – | – | – | 1 | – | – | – | – | – |
Rasouli et al. | 2014 | 15 | – | – | – | – | – | – | 600 | 4923 | 5 | – | – | – | – | – | – | 95 | 522 |
Reuben et al. | 1998 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Saito et al. | 2010 | 0 | 0 | – | – | 1 | 1 | – | – | – | 0 | 0 | – | – | 0 | 0 | – | – | – |
Salvati et al. | 1978 | 0 | – | – | – | – | – | – | – | – | 1 | – | – | – | – | – | – | – | – |
Schlegelmilch et al. | 2017 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Seol et al. | 2015 | 0 | 1 | – | 1 | – | 0 | – | – | 0 | 0 | 2 | – | 0 | – | 0 | – | – | 0 |
Shih et al. | 1985 | 0 | – | 1 | 1 | 0 | – | – | 0 | 0 | 0 | – | 0 | 0 | 0 | – | – | 1 | 0 |
Taheriazam et al. | 2019 | 0 | 0 | 0 | 0 | 1 | 0 | – | 2 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | – | 0 | 1 |
Tan et al. | 2019 | 0 | – | – | – | 3 | 0 | – | 3 | 5 | 0 | – | – | – | 3 | 0 | – | 1 | 3 |
Triantafyllopoulos et al. | 2016 | – | 9 | – | – | – | – | – | – | 0 | – | 19 | – | – | – | – | – | – | 0 |
Villa et al. | 2019 | – | 1 | 0 | – | 0 | 0 | – | 3 | 19 | – | 1 | 1 | – | 0 | 2 | – | 2 | 60 |
Perioperative and postoperative relevant outcomes
Author | Year | Simultaneous bilateral THA | Staged bilateral THA | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Operation time (min) | Hospital LOS (days) | Operation cost ($) | Transfusion (units) | Blood loss (ml) | Operation time (min) | Hospital LOS (days) | Operation cost ($) | Transfusion (units) | Blood loss (ml) | ||
Agarwal et al. | 2016 | – | 5.6 ± 0.8 | – | 1.6 ± 1.1 | 280 ± 86.7 | – | 9 ± 1.0 | – | 2.2 ± 1.5 | 440 ± 120.0 |
Aghayev et al. | 2010 | – | – | – | – | – | – | – | – | – | – |
Alfaro-Adrián et al. | 1999 | 202.6 ± 52.5 | 17 ± 9.0 | 9300 ± 750.0 | 3.9 ± 2.0 | 1579 ± 590.3 | 205.9 ± 41.3 | 23 ± 8.0 | 11,200 ± 860.0 | 2.7 ± 2.2 | 1862 ± 639.3 |
Berend et al. | 2007 | – | 3.9 ± 1.5 | – | 0.8 ± 1.1 | – | – | 5.6 ± 1.9 | – | 0.4 ± 0.8 | – |
Bhan et al. | 2006 | 207.42 ± 37.8 | 7.3 ± 1.3 | – | 2.4 ± 0.8 | 1473.9 ± 517.1 | 215.6 ± 37.4 | 10 ± 1.7 | – | 1.8 ± 1.1 | 1997.1 ± 490.8 |
Brown et al. | 2017 | – | 5 ± 2.3 | – | – | – | – | 7.7 ± 2.8 | – | – | – |
Calabro et al. | 2020 | – | – | – | – | – | – | – | – | – | – |
Eggli et al. | 1995 | – | 14 ± 4.0 | – | – | – | – | 19.6 ± 7.6 | – | – | – |
Garland et al. | 2015 | – | – | – | – | – | – | – | – | – | – |
Goh et al. | 2022 | 162 ± 9.0 | – | 23,863 ± 900.0 | – | – | 198 ± 6.5 | – | 26,320 ± 700.0 | – | – |
Guo et al. | 2020 | – | 11 ± 1.0 | – | 4 ± 0.7 | – | – | 20 ± 1.8 | – | 4 ± 1.0 | – |
Hooper et al. | 2009 | – | – | – | – | – | – | – | – | – | – |
Hou et al. | 2021 | – | 9 ± 0.7 | 14,503 ± 756.0 | – | – | – | 15 ± 1.0 | 16,142 ± 1034.7 | – | – |
Houdek et al. | 2017 | 176 ± 53.0 | 4.6 ± 4.1 | – | 2 ± 1.3 | – | 211 ± 72.0 | 5.9 ± 2.4 | – | 1.9 ± 1.4 | – |
Inoue et al. | 2021 | – | 1.8 ± 0.8 | – | – | – | – | 2.8 ± 2.2 | – | – | – |
Johnston et al. | 2011 | – | – | – | – | – | – | – | – | – | – |
Kamath et al. | 2016 | 134.8 ± 29.1 | 11.2 ± 3.4 | – | – | 738.8 ± 519.2 | 151.5 ± 28.8 | 15.2 ± 5.8 | – | – | 943.2 ± 423.0 |
Kim et al. | 2017 | 172 ± 24.0 | 10.5 ± 5.8 | 12,608 ± 2950.0 | – | 1037 ± 321.0 | 162 ± 40.0 | 18.7 ± 8.7 | 14,910 ± 4080.0 | – | 1145 ± 518.0 |
Lindberg‑Larsen et al. | 2013 | – | 6.2 ± 18 | – | – | – | – | 6.7 ± 10.0 | – | – | – |
Lorenze et al. | 1998 | – | 10 ± 3.5 | 26,645 ± 3600 | – | 535 ± 105.0 | – | 16 ± 5.0 | 34,964 ± 5100.0 | – | 1100 ± 270.0 |
Martin et al. | 2016 | 130.3 ± 19.9 | 2.2 ± 0.9 | 9831 ± 505.1 | – | – | 139.4 ± 22.0 | 2.4 ± 0.2 | 11,544.8 ± 468.4 | – | – |
Mou et al. | 2021 | – | – | 17,139 ± 1015.0 | 3 ± 3.9 | – | – | – | 17,861 ± 1066 | 0.77 ± 2.0 | – |
Panchal et al. | 2021 | – | – | – | – | – | – | – | – | – | – |
Partridge et al. | 2019 | – | 8.9 ± 0.7 | – | – | – | – | 10.4 ± 1.2 | – | – | – |
Parvizi et al. | 2006 | 131.72 ± 24.4 | 4.3 ± 2.2 | 45,900 | 2.61 ± 1.8 | 443 ± 152.3 | 132.3 ± 62.6 | 8.1 ± 10.3 | 64,600 | 3.5 ± 3.5 | 513 ± 629.0 |
Poultsides et al. | 2017 | – | – | – | – | – | – | – | – | – | – |
Quadri et al. | 2015 | 273 ± 58.2 | 8.1 ± 3.2 | – | 1.2 ± 1.3 | – | 358 ± 72.6 | 19.6 ± 5.0 | – | 2.3 ± 2.6 | – |
Rasouli et al. | 2014 | – | – | – | – | – | – | – | – | – | – |
Reuben et al. | 1998 | – | 7.6 ± 1.1 | 24,067 ± 4264.7 | – | – | – | 14.5 ± 1.8 | 28,404 ± 1146.3 | – | – |
Saito et al. | 2010 | 159 ± 32.0 | 39.6 ± 12 | – | – | 1018 ± 609.0 | 179 ± 19.0 | 60.6 ± 6.5 | – | – | 1019 ± 358.0 |
Salvati et al. | 1978 | – | – | – | – | 1944 ± 694 | – | – | – | – | 2818 ± 900.0 |
Schlegelmilch et al. | 2017 | – | – | 5735 ± 100.0 | – | – | – | – | 10,143 ± 346.0 | – | – |
Seol et al. | 2015 | – | 14.6 ± 8.1 | 9236 ± 1231.0 | 3.0 ± 2.6 | 926.4 ± 341.2 | – | 25.3 ± 9.8 | 11,163 ± 1588.4 | 1.9 ± 2.2 | 978 ± 389.3 |
Shih et al. | 1985 | 148 ± 14.0 | 17.9 ± 6.0 | – | – | 1202 ± 332.0 | 245 ± 16.0 | 27.3 ± 10.9 | – | – | 1410 ± 230.0 |
Taheriazam et al. | 2019 | 162 ± 18.0 | 4.9 ± 1.0 | – | 1.9 ± 1.3 | 512 ± 45.0 | 199.7 ± 16.0 | 9.8 ± 1.4 | – | 2.7 ± 2.1 | 538 ± 390.0 |
Tan et al. | 2019 | – | 8.7 ± 5.3 | 19,627 ± 5441.0 | – | – | – | 12.1 ± 5.6 | 19,667 ± 5441.0 | – | – |
Triantafyllopoulos et al. | 2016 | – | 5.2 ± 2.5 | – | 1.2 ± 1.1 | – | – | 8.1 ± 2.8 | – | 1.1 ± 1.2 | – |
Villa et al. | 2019 | – | 2.6 ± 1.2 | – | – | – | – | 1.8 ± 1.0 | – | – | – |
Author | Year | Simultaneous bilateral THA | Staged bilateral THA | ||||||
---|---|---|---|---|---|---|---|---|---|
Revision (n) | Readmission (n) | Postoperative LLD (mm) | Postoperative HHS | Revision (n) | Readmission (n) | Postoperative LLD (mm) | Postoperative HHS | ||
Agarwal et al. | 2016 | – | – | 10 ± 3.0 | 92.3 ± 1.2 | – | – | 9 ± 3.5 | 90.8 ± 1.1 |
Aghayev et al. | 2010 | – | – | – | 94.2 ± 2.0 | – | – | – | 91 ± 3.0 |
Alfaro-Adrián et al. | 1999 | 5 | – | – | – | 7 | – | – | – |
Berend et al. | 2007 | – | 13 | – | – | – | 1 | – | – |
Bhan et al. | 2006 | 3 | – | 4.5 ± 4.4 | 82 ± 5.0 | 3 | – | 5.3 ± 4.6 | 83.5 ± 6.0 |
Brown et al. | 2017 | – | – | 3.5 ± 2.7 | – | – | – | 3.8 ± 3.0 | – |
Calabro et al. | 2020 | 121 | – | – | – | 500 | – | – | – |
Eggli et al. | 1995 | – | – | 2.2 ± 1.8 | – | – | – | 2.2 ± 1.4 | – |
Garland et al. | 2015 | 240 | – | – | – | 4897 | – | – | – |
Goh et al. | 2022 | – | – | – | – | – | – | – | – |
Guo et al. | 2020 | – | 14 | – | – | – | 5 | – | – |
Hooper et al. | 2009 | – | – | – | – | – | – | – | – |
Hou et al. | 2021 | – | – | – | – | – | – | – | – |
Houdek et al. | 2017 | 7 | 9 | – | – | 13 | 15 | – | – |
Inoue et al. | 2021 | – | – | – | – | – | – | – | – |
Johnston et al. | 2011 | 1 | 16 | – | 78.9 ± 10.3 | 8 | 142 | – | 82.2 ± 13.4 |
Kamath et al. | 2016 | – | – | 1.1 ± 1.8 | – | – | – | 1.3 ± 1.7 | – |
Kim et al. | 2017 | 2 | – | 2.1 ± 2.0 | 95.9 ± 4.8 | 4 | – | 4.3 ± 3.2 | 90.7 ± 8.2 |
Lindberg‑Larsen et al. | 2013 | – | 2 | – | – | – | 33 | – | – |
Lorenze et al. | 1998 | – | – | – | – | – | – | – | – |
Martin et al. | 2016 | – | – | – | – | – | – | – | – |
Mou et al. | 2021 | – | – | 4.8 ± 3.9 | 84 ± 2.8 | – | – | 4.5 ± 3.1 | 83.4 ± 2.0 |
Panchal et al. | 2021 | – | – | – | – | – | – | – | – |
Partridge et al. | 2019 | – | 55 | – | – | – | 198 | – | – |
Parvizi et al. | 2006 | 0 | – | – | 91 ± 3.0 | 3 | – | – | 89 ± 3.0 |
Poultsides et al. | 2017 | – | – | – | – | – | – | – | – |
Quadri et al. | 2015 | 0 | – | – | – | 1 | – | – | – |
Rasouli et al. | 2014 | – | – | – | – | – | – | – | – |
Reuben et al. | 1998 | – | – | – | – | – | – | – | – |
Saito et al. | 2010 | – | – | – | 87.8 ± 4.0 | – | – | – | 87.3 ± 2.6 |
Salvati et al. | 1978 | – | – | – | – | – | – | – | – |
Schlegelmilch et al. | 2017 | – | – | – | – | – | – | – | – |
Seol et al. | 2015 | – | – | – | 96.4 | – | – | – | 94.8 |
Shih et al. | 1985 | – | – | – | – | – | – | – | – |
Taheriazam et
al. | 2019 | 0 | – | – | 84.1 ± 3.0 | 0 | – | – | 82.6 ± 3.1 |
Tan et al. | 2019 | 1 | – | – | – | 1 | – | – | – |
Triantafyllopoulos et al. | 2016 | – | – | – | – | – | – | – | – |
Villa et al. | 2019 | – | – | – | – | – | – | – | – |